Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

OBJECTIVE: Blood‐based biomarkers for neurodegenerative conditions could improve diagnosis and treatment development. Neurofilament light chain (NfL), a marker of axonal injury, is elevated in cerebrospinal fluid (CSF) of patients with progressive supranuclear palsy (PSP). The goal of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Julio C., Karydas, Anna, Bang, Jee, Tsai, Richard M., Blennow, Kaj, Liman, Victor, Kramer, Joel H., Rosen, Howard, Miller, Bruce L., Zetterberg, Henrik, Boxer, Adam L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774256/
https://www.ncbi.nlm.nih.gov/pubmed/27042681
http://dx.doi.org/10.1002/acn3.290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774256/
https://www.ncbi.nlm.nih.gov/pubmed/27042681
http://dx.doi.org/10.1002/acn3.290

Ejemplares similares